157 related articles for article (PubMed ID: 12670347)
21. Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells.
Li G; Yang T; Yan J
Biochem Biophys Res Commun; 2002 Dec; 299(5):886-90. PubMed ID: 12470662
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
24. The contributions of cyclooxygenase-2 to tumor angiogenesis.
Gately S
Cancer Metastasis Rev; 2000; 19(1-2):19-27. PubMed ID: 11191059
[TBL] [Abstract][Full Text] [Related]
25. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
26. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M
Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.
Gallo O; Franchi A; Magnelli L; Sardi I; Vannacci A; Boddi V; Chiarugi V; Masini E
Neoplasia; 2001; 3(1):53-61. PubMed ID: 11326316
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor.
Murphy JF; Fitzgerald DJ
FASEB J; 2001 Jul; 15(9):1667-9. PubMed ID: 11427521
[No Abstract] [Full Text] [Related]
29. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
[TBL] [Abstract][Full Text] [Related]
30. Sustained pulsatile flow regulates endothelial nitric oxide synthase and cyclooxygenase expression in co-cultured vascular endothelial and smooth muscle cells.
Hendrickson RJ; Cappadona C; Yankah EN; Sitzmann JV; Cahill PA; Redmond EM
J Mol Cell Cardiol; 1999 Mar; 31(3):619-29. PubMed ID: 10198192
[TBL] [Abstract][Full Text] [Related]
31. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.
Murono S; Inoue H; Tanabe T; Joab I; Yoshizaki T; Furukawa M; Pagano JS
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6905-10. PubMed ID: 11381123
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
33. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia.
Lukiw WJ; Ottlecz A; Lambrou G; Grueninger M; Finley J; Thompson HW; Bazan NG
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4163-70. PubMed ID: 14507857
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S
Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802
[TBL] [Abstract][Full Text] [Related]
35. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2.
Caughey GE; Cleland LG; Penglis PS; Gamble JR; James MJ
J Immunol; 2001 Sep; 167(5):2831-8. PubMed ID: 11509629
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of cyclooxygenase (COX)-2 inhibits endothelial cell proliferation by induction of cell cycle arrest.
Yazawa K; Tsuno NH; Kitayama J; Kawai K; Okaji Y; Asakage M; Sunami E; Kaisaki S; Hori N; Watanabe T; Takahashi K; Nagawa H
Int J Cancer; 2005 Feb; 113(4):541-8. PubMed ID: 15472909
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells.
Uracz W; Uracz D; Olszanecki R; Gryglewski RJ
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):643-54. PubMed ID: 12512699
[TBL] [Abstract][Full Text] [Related]
39. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma.
Jaeckel EC; Raja S; Tan J; Das SK; Dey SK; Girod DA; Tsue TT; Sanford TR
Arch Otolaryngol Head Neck Surg; 2001 Oct; 127(10):1253-9. PubMed ID: 11587608
[TBL] [Abstract][Full Text] [Related]
40. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.
Barry OP; Pratico D; Lawson JA; FitzGerald GA
J Clin Invest; 1997 May; 99(9):2118-27. PubMed ID: 9151784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
